FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

437011000001104: Actiq 400microgram lozenges with integral oromucosal applicator (Cephalon UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17328101000001114 Actiq 400microgram lozenges with integral oromucosal applicator (Cephalon UK Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
67054001000001110 Actiq 400microgram lozenges with integral oromucosal applicator (Teva UK Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Actiq 400microgram lozenges with integral oromucosal applicator (Cephalon UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Actiq 400microgram lozenges with integral oromucosal applicator (Cephalon UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 2 (CD) true Inferred relationship Existential restriction modifier
Actiq 400microgram lozenges with integral oromucosal applicator (Cephalon UK Ltd) Is a Product containing precisely fentanyl 400 microgram/1 each conventional release oromucosal lozenge (clinical drug) true Inferred relationship Existential restriction modifier
Actiq 400microgram lozenges with integral oromucosal applicator (Cephalon UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Actiq 400microgram lozenges with integral oromucosal applicator (Cephalon UK Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Actiq 400microgram lozenges with integral oromucosal applicator (Cephalon UK Ltd) Has active ingredient Fentanyl citrate false Inferred relationship Existential restriction modifier
Actiq 400microgram lozenges with integral oromucosal applicator (Cephalon UK Ltd) Has active ingredient Fentanyl true Inferred relationship Existential restriction modifier
Actiq 400microgram lozenges with integral oromucosal applicator (Cephalon UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Actiq 400microgram lozenges with integral oromucosal applicator (Cephalon UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Actiq 400microgram lozenges with integral oromucosal applicator (Cephalon UK Ltd) Has manufactured dose form Lozenge false Inferred relationship Existential restriction modifier
Actiq 400microgram lozenges with integral oromucosal applicator (Cephalon UK Ltd) Is a Actiq true Inferred relationship Existential restriction modifier
Actiq 400microgram lozenges with integral oromucosal applicator (Cephalon UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Fentanyl true Inferred relationship Existential restriction modifier
Actiq 400microgram lozenges with integral oromucosal applicator (Cephalon UK Ltd) Has specific active ingredient Fentanyl citrate true Inferred relationship Existential restriction modifier
Actiq 400microgram lozenges with integral oromucosal applicator (Cephalon UK Ltd) Has dispensed dose form Lozenge true Inferred relationship Existential restriction modifier
Actiq 400microgram lozenges with integral oromucosal applicator (Cephalon UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Actiq 400microgram lozenges with integral oromucosal applicator (Cephalon UK Ltd) Has manufactured dose form Lozenge false Inferred relationship Existential restriction modifier
Actiq 400microgram lozenges with integral oromucosal applicator (Cephalon UK Ltd) Has basis of strength substance Fentanyl true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Actiq 400microgram lozenges with integral oromucosal applicator (Cephalon UK Ltd) 30 lozenge Is pack of False Actiq 400microgram lozenges with integral oromucosal applicator (Cephalon UK Ltd) Inferred relationship Existential restriction modifier
Actiq 400microgram lozenges with integral oromucosal applicator (Cephalon UK Ltd) 3 lozenge Is pack of False Actiq 400microgram lozenges with integral oromucosal applicator (Cephalon UK Ltd) Inferred relationship Existential restriction modifier
Actiq 400microgram lozenges with integral oromucosal applicator (Cephalon UK Ltd) 30 lozenge Has AMP True Actiq 400microgram lozenges with integral oromucosal applicator (Cephalon UK Ltd) Inferred relationship Existential restriction modifier
Actiq 400microgram lozenges with integral oromucosal applicator (Cephalon UK Ltd) 3 lozenge Has AMP True Actiq 400microgram lozenges with integral oromucosal applicator (Cephalon UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start